Literature DB >> 20661839

HIV-associated prospective memory impairment in the laboratory predicts failures on a semi-naturalistic measure of health care compliance.

Jennifer B Zogg1, Steven Paul Woods, Erica Weber, Jennifer E Iudicello, Matthew S Dawson, Igor Grant.   

Abstract

HIV-associated neurocognitive impairment, particularly in the domain of prospective memory (ProM), increases the risk of poor everyday functioning outcomes, including medication non-adherence. However, whether ProM plays a role in health care compliance outside of the realm of medication adherence remains to be determined. This study evaluated the hypothesis that ProM is an independent predictor of failure to comply with non-medication-related instructions akin to those commonly given by health care providers. Participants were 139 HIV-infected adults who underwent medical, psychiatric, and neuropsychological assessments, including a laboratory-based measure of ProM. To assess real-world compliance, participants were instructed to call the examiner 24 hours after the evaluation and report how many hours they had slept. Individuals who failed to correctly comply with these instructions (n = 104) demonstrated significantly lower performance on both time- and event-based ProM at baseline than the compliant group (n = 35), an effect that was primarily driven by errors of omission. ProM remained a significant predictor of noncompliance after controlling for potential confounders, including demographics (e.g., education), traditional cognitive measures of retrospective memory and executive functions, and psychiatric factors (e.g., depression). Results support the hypothesis that ProM plays a unique role in compliance with health care instructions for HIV disease management and may inform interventions designed to improve treatment outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20661839      PMCID: PMC3268682          DOI: 10.1080/13854046.2010.501343

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  34 in total

1.  The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group.

Authors:  T D Marcotte; R K Heaton; T Wolfson; M J Taylor; O Alhassoon; K Arfaa; R J Ellis; I Grant
Journal:  J Int Neuropsychol Soc       Date:  1999-11       Impact factor: 2.892

2.  Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Authors:  D R Bangsberg; S Perry; E D Charlebois; R A Clark; M Roberston; A R Zolopa; A Moss
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

3.  Is the influence of social desirability on patients' self-reported adherence overrated?

Authors:  Glenn Wagner; Loren G Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

4.  Role of ethnicity in predicting antipsychotic medication adherence.

Authors:  Jayme L Opolka; Karen L Rascati; Carolyn M Brown; P Joseph Gibson
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

5.  Prospective and retrospective memory in normal ageing and dementia: a questionnaire study.

Authors:  G Smith; S Della Sala; R H Logie; E A Maylor
Journal:  Memory       Date:  2000-09

6.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

Review 7.  Adherence in chronic disease.

Authors:  J Dunbar-Jacob; J A Erlen; E A Schlenk; C M Ryan; S M Sereika; W M Doswell
Journal:  Annu Rev Nurs Res       Date:  2000

8.  Self-regulation predictors of medication adherence among ethnically different pediatric patients with renal transplants.

Authors:  C M Tucker; S Petersen; K C Herman; R S Fennell; B Bowling; T Pedersen; J R Vosmik
Journal:  J Pediatr Psychol       Date:  2001-12

9.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

10.  Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities.

Authors:  Robert H Remien; A Elizabeth Hirky; Mallory O Johnson; Lance S Weinhardt; David Whittier; Giang Minh Le
Journal:  AIDS Behav       Date:  2003-03
View more
  21 in total

1.  Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND).

Authors:  Erin E Morgan; Erica Weber; Alexandra S Rooney; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-02-02       Impact factor: 2.475

2.  Prospective memory in substance abusers at treatment entry: associations with education, neuropsychological functioning, and everyday memory lapses.

Authors:  Michael Weinborn; Steven Paul Woods; Stephanie O'Toole; Emily J Kellogg; Jonson Moyle
Journal:  Arch Clin Neuropsychol       Date:  2011-09-08       Impact factor: 2.813

3.  A systematic review of prospective memory in HIV disease: from the laboratory to daily life.

Authors:  Gunes Avci; David P Sheppard; Savanna M Tierney; Victoria M Kordovski; Kelli L Sullivan; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2017-09-27       Impact factor: 3.535

4.  Habitual prospective memory in HIV disease.

Authors:  Katie L Doyle; Erica Weber; Erin E Morgan; Shayne Loft; Clint Cushman; Javier Villalobos; Elaine Johnston; Steven Paul Woods
Journal:  Neuropsychology       Date:  2015-03-02       Impact factor: 3.295

5.  Allowing brief delays in responding improves event-based prospective memory for young adults living with HIV disease.

Authors:  Shayne Loft; Katie L Doyle; Sylvie Naar-King; Angulique Y Outlaw; Sharon L Nichols; Erica Weber; Kaitlin B Casaletto; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2014-08-13       Impact factor: 2.475

6.  Construct validity of the Memory for Intentions Screening Test (MIST) in healthy older adults.

Authors:  Rujvi Kamat; Michael Weinborn; Emily J Kellogg; Romola S Bucks; Aimee Velnoweth; Steven Paul Woods
Journal:  Assessment       Date:  2014-04-21

Review 7.  The role of prospective memory in medication adherence: a review of an emerging literature.

Authors:  Jennifer B Zogg; Steven Paul Woods; John A Sauceda; John S Wiebe; Jane M Simoni
Journal:  J Behav Med       Date:  2011-04-13

8.  Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy.

Authors:  Torsak Bunupuradah; Ploenchan Chetchotisakd; Supunnee Jirajariyavej; Victor Valcour; Chureeratana Bowonwattanuwong; Warangkana Munsakul; Virat Klinbuayaem; Wisit Prasithsirikul; Jiratchaya Sophonphan; Apicha Mahanontharit; Bernard Hirschel; Sorakij Bhakeecheep; Kiat Ruxrungtham; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2012-09-20       Impact factor: 2.643

9.  Prospective memory deficits are associated with poorer everyday functioning in Parkinson's disease.

Authors:  Eva Pirogovsky; Steven Paul Woods; J Vincent Filoteo; Paul E Gilbert
Journal:  J Int Neuropsychol Soc       Date:  2012-07-30       Impact factor: 2.892

10.  The role of decision-making ability in HIV/AIDS: impact on prospective memory.

Authors:  Kelly Coulehan; Desiree Byrd; Alyssa Arentoft; Jennifer Monzones; Armando Fuentes; Felicia Fraser; Ana Rosario; Susan Morgello; Monica Rivera Mindt
Journal:  J Clin Exp Neuropsychol       Date:  2014-08-04       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.